RMD dividend history

- Year-over-year operating profit up 3%, non-GAAP operating profit up 2% Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE:RMD, ASX: RMD))), a world-leading digital health company, today announced results for its quarter ended March 31, 2021. Third Quarter 2021 HighlightsAll comparisons are to the prior year period Revenue was comparable at $768.8 million; down 3% on a constant currency basisGAAP gross margin of 58.2%; non-GAAP gross margin contracted 40 bps to 59.6%Net operating profit increased 3%; non-GAAP operating profit up 2%GAAP diluted earnings (loss)

SAN DIEGO--(BUSINESS WIRE)--ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended December 31, 2020. Second Quarter 2021 Highlights All comparisons are to the prior year period Revenue increased 9% to $800.0 million; up 7% on a constant currency basis GAAP gross margin of 57.8%; non-GAAP gross margin expanded 20 bps to 59.9% Net operating profit increased 12%; non-GAAP operating profit up 16% GAAP diluted earnings per share of $1.23; non-GAAP diluted earnings per share of $1.41 “Our second-quarter results reflect continued solid performance and positive trends across our business resulting in top-line g